Mostly Markets
Subscribe
Stocks/Health Care/Health Care Services

CVS HealthCVS

Health Care Services · Woonsocket, Rhode Island · In the S&P 500
Cheaper than peers
$90.25−0.09%After hours: $90.25 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 12.0% over 1 year
CVS Health over 1 yearDaily close, $, to 30 Oct 2026
$80$100Nov2026MarMayJulSep$90.25$80$100NovMarJul$90.25
Source: Nasdaq daily closes
Market value$115B
Price to earnings23.9x
Forward P/E11.1x
Dividend yield2.95%
Year to date+13.7%
One year+12.0%
Next earningsWed 4 Nov, before the open
SectorHealth Care
52-week range (closes)
$70.08$110.60

Quality and valuation

How CVS Health compares with other health care stocks. A description, not a recommendation.

CVS Health and 5 health care services peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: weaker than mostValuation: cheaper than most

A weaker business than most health care companies, priced below most of them.

CVS Health trades at 11.1 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +7.4% vs +7.8%
  • Keeps less of each sale (gross margin): 44.5% vs 65.3%
  • Less profitable (operating margin): 2.0% vs 13.3%
  • Turns less of its sales into cash: 2.8% vs 15.9%
CVS trades at 11.1x forward earnings, below the sector medianForward p/e, Health Care Services peers
CI9.4xCVS11.1xDVA11.9xLH19.1xDGX22.2xHIMS73.4xSector median 19.1xCI9.4xCVS11.1xDVA11.9xLH19.1xDGX22.2xHIMS73.4xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 23.9x earnings, CVS is cheaper than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
0x100x200xAverage 47.3x2025202623.9x0x100x200xAverage 47.3x2025202623.9x
Source: Nasdaq prices; SEC filings

Financials

From CVS Health's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 7.3% from a year earlierQuarterly revenue, $bn, latest Q2 ’26
$0bn$50bn$100bnQ3 ’24Q1 ’25Q3 ’25$106bnQ2 ’26$0bn$50bn$100bnQ3 ’24Q1 ’25Q3 ’25$106bnQ2 ’26
Source: SEC filings
Growth sped up to +7.3% last quarterRevenue growth, year on year, %
0%2%5%8%Q3 ’24Q1 ’25Q3 ’257.3%Q2 ’260%5%Q3 ’24Q1 ’25Q3 ’257.3%Q2 ’26
Source: SEC filings
Operating margin was 4.4% last quarterOperating income as a share of revenue, %
−2%0%2%4%Q3 ’24Q1 ’25Q3 ’254.4%Q2 ’260%Q3 ’24Q1 ’25Q3 ’254.4%Q2 ’26
Source: SEC filings
Free cash flow was $11.8 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $bn
$0bn$2bn$4bnQ3 ’24Q1 ’25Q3 ’25$5.7bnQ2 ’26$0bn$2bn$5bnQ3 ’24Q1 ’25Q3 ’25$5.7bnQ2 ’26
Source: SEC filings
Last 12 monthsCVSSector median
Revenue growth+7.4%+7.8%
Gross margin44.5%65.3%
Operating margin2.0%13.3%
Free cash flow margin2.8%15.9%
Price to earnings23.9x30.2x

Stories on CVS Health

We haven't written about CVS Health yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Services, by market value.

CompanyPriceTodayYTDValue
CICigna$298.23−0.06%+8.4%$78.80B
LHLabcorp$361.39−1.84%+44.0%$29.34B
DGXQuest Diagnostics$251.82−0.43%+45.1%$27.70B
DVADaVita$187.50−3.01%+65.0%$11.96B
HIMSHims & Hers Health$27.68−6.71%−14.8%$6.46B